Indian Pharmaceutical Alliance

26/01/2025

The well-being of its people defines a nation’s true progress, and Indian pharma is steadfast in its commitment to advancing healthcare. IPA wishes you all a very Happy !

15/01/2025

India’s pharmaceutical sector has cemented its position as the 'Pharmacy of the World', playing a central role in global healthcare and innovation.

As we enter 2025, Samir Mehta, Chairman, Torrent Pharmaceuticals Limited and President, Indian Pharmaceutical Alliance, delves into the four pillars—Innovation, Institutions, Integration, and Infrastructure—that will propel the growth of the Indian pharmaceutical industry, aligning with the vision of a Viksit Bharat.

Read more on Fortune India: https://bit.ly/41WxGFr

India’s role in the new global order has never been more apparent than during the recent battle against the COVID-19 pandemic.

13/01/2025

In the latest episode of the State of Economy Podcast, The Hindu Business Line's Jyothi Datta speaks with Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance (IPA), who outlined the key highlights of Indian Pharma in 2024.

Looking ahead to 2025, Mr. Jain shares his perspective on how India can strengthen its export market amidst geopolitical shifts and increasing global demand for affordable healthcare solutions

Link to podcast: https://bit.ly/3ZXZ8Qw

Explore the achievements and challenges of India's pharmaceutical industry in 2024 with Sudharshan Jain on the State of Economy Podcast.

19/12/2024

We are pleased to inform that the tenth edition of IPA's flagship event, the Global Pharmaceutical Quality Summit (GPQS) will be held on 27-28 February 2025 (in-person) in Mumbai.

This year marks a decade of the Indian pharmaceutical industry's commitment to advancing the quality agenda. With the theme, 'Navigating the Next Decade for Global Excellence', this year's focus is on charting the path towards making India the global benchmark in quality.

Join us on 27-28 February 2025 at JW Marriott Juhu, Mumbai as we celebrate a decade of advancing pharmaceutical manufacturing and quality standards. Connect with industry leaders, global regulators, and government officials for deep insights and meaningful discussions.

Register now: https://10gpqs.ipa-india.org/register-for-10th-gpqs/

18/12/2024

18/12/2024

We are pleased to inform that the tenth edition of IPA's flagship event, the Global Pharmaceutical Quality Summit (GPQS) will be held on 27-28 February 2025 (in-person) in Mumbai. This year marks a decade of the Indian pharmaceutical industry's commitment to advancing the quality agenda. With the theme, 'Navigating the Next Decade for Global Excellence', this year's focus is on charting the path towards making India the global benchmark in quality.

Join us on 27-28 February 2025 at JW Marriott Juhu, Mumbai as we celebrate a decade of advancing pharmaceutical manufacturing and quality standards. Connect with industry leaders, global regulators, and government officials for deep insights and meaningful discussions.

Register now: https://10gpqs.ipa-india.org/register-for-10th-gpqs/

17/12/2024

14/11/2024

celebrates the power of biosimilars in making healthcare more affordable and accessible.

IGBA returns with the 5th Edition of Global BioSimilars Week, under the theme 'Advancing Access to Biosimilars.' This event aims to highlight the transformative power of biosimilars in improving healthcare worldwide. Open to patients, healthcare providers, government representatives, and anyone interested in learning more, the event is a unique opportunity to explore the potential of biosimilars.

Learn more about it here: https://www.globalbiosimilarsweek.org/2024/

13/11/2024

Advancing Access to Biosimilars

IGBA is back with the 5th Edition of Global BioSimilars Week, themed 'Advancing Access to Biosimilars.' The mission of this event is to raise awareness about the powerful and life-changing impact of biosimilar medicines. The event is open to patients, healthcare professionals, government organizations, and other interested parties.

Join us at the Global Biosimilars Week by signing up for the complimentary webinar on November 13, 15:00-16:30 CET / 9:00-10:30 EST on Streamlining the Regulatory Process to Advance Access to Biosimilars.

Speakers:
Ali Alhomaidan, Senior Scientific Consultant, Saudi Food & Drug Authority
Ivana Knezevic, Scientist, Team Leader, Norms and Standards for Biologicals, HPS/MHP/WHO
Peter Richardson, Senior Quality Specialist, European Medicines Agency
Sarah Yim, Director, Office of Therapeutic Biologics and Biosimilars, FDA
Skylar Jeremias, Senior Editor, The Center for Biosimilars
Moderator: Giuseppe Randazzo, Senior Vice President, Sciences and Regulatory Affairs Association for Accessible Medicine

You can register for the webinar here: http://www.globalbiosimilarsweek.org

28/10/2024

The IPA Masterclass, 'GenAI in Pharma,' in collaboration with McKinsey & Company, is just 1 hour away.

Join the global experts as they dive into GenAI’s transformative role, its applications across pharmaceutical functions, and its adoption in India. The event will conclude with a live Q&A. You will have an opportunity to interact with the experts during live Q&A, which will be moderated by Shridhar Narayan.

Registered participants can join the webinar here: https://zoom.us/j/99698864237

27/10/2024

Just one day to go for IPA Masterclass on 'GenAI in Pharma,' in collaboration with McKinsey & Company, taking place on 28 October 2024, from 5:30 to 7:00 pm IST on a virtual platform! Don’t miss this opportunity to learn and engage with industry experts.

Join global industry experts at our masterclass to explore the transformative potential of generative AI within the pharmaceutical industry. Featured speakers include Joachim Bleys, Global Co-Leader of QuantumBlack for Life Sciences at McKinsey, advising top pharma and biotech clients; Alex Devereson, McKinsey Partner, supporting biopharma innovation through R&D transformation; and Anirudh Roy Popli, McKinsey’s India Life Sciences R&D leader, specializing in Indian pharma and biotech solutions.

Register now: forms.gle/bNNp2pykGtbwDSwK7

26/10/2024

The IPA Masterclass, 'GenAI in Pharma', in collaboration with McKinsey & Company, will be conducted on virtual platform on 28 October 2024, 5.30 pm - 7.00 pm IST.

Explore the transformative potential of generative AI in the pharmaceutical industry with global leaders. Featured speakers include Joachim Bleys, Global Co-Leader of QuantumBlack for Life Sciences and AI by McKinsey; Alex Devereson, McKinsey Partner specializing in biopharma innovation; and Anirudh Roy Popli, India Life Sciences R&D Leader at McKinsey.

Register now: https://forms.gle/bNNp2pykGtbwDSwK7

25/10/2024

The IPA Masterclass, ‘GenAI in Pharma’, in collaboration with McKinsey & Company, will explore the impact of GenAI, its applications across functions in the pharmaceutical industry, and how this trend is being adopted in India. The session will be followed by a live Q&A, moderated by Dr Shridhar Narayanan, Sr Technical Advisor, IPA.

Date: 28 October 2024
Time: 5:30 – 7:00 pm IST
Virtual

Register here: https://bit.ly/4eDr9CR

22/10/2024

IPA’s 9th Advanced GMP Workshop 2024 will start in just 3 hours. If you haven’t registered yet, here’s your final chance to secure your spot!

Date: 22 – 23 October 2024
Time: 3:00 – 8:00 pm IST
Virtual

Register Now: https://bit.ly/4gHz9nS

Lupin India U.S. Food and Drug Administration Department of Pharmaceuticals Dr. Reddy's Laboratories Ltd. Sun Pharmaceutical Industries Limited Cipla

21/10/2024

Join us for an insightful panel discussion on Strengthening Quality Assurance in Clinical & BA/BE Studies at IPA’s 9th Advanced GMP Workshop 2024.

Meet Our Panelists for the session:
Rajendra Bangar - Head of Development Quality Assurance at Dr. Reddy's Laboratories Ltd.
Arshad Khuroo - Head of Bioavailability and Bioequivalence at Sun Pharmaceutical Industries Limited
M E Kannan - President & Head of Research & Development at Zydus Lifesciences
Samantha Atkinson - Executive VP & Principal Consultant, Lifesciences at NSF
Dharmesh Domadia - Head, Global Clinical Operations, Cliantha Research

Moderator:
Shirish Belapure - Senior Technical Advisor, Indian Pharmaceutical Alliance

Date: 22 – 23 October 2024
Time: 3:00 – 8:00 pm IST
Virtual

Register Now: https://bit.ly/4gHz9nS

21/10/2024

Just one day to go for IPA’s 9th Advanced GMP Workshop 2024. Strengthen your GMP expertise with insights from regulators, government officials, industry experts and consultants.

Date: 22 – 23 October 2024
Time: 3:00 – 8:00 pm IST
Virtual

Register Now: https://bit.ly/4gHz9nS

Lupin India U.S. Food and Drug Administration Department of Pharmaceuticals Dr. Reddy's Laboratories Ltd. Sun Pharmaceutical Industries Limited Cipla

19/10/2024

Mahesh Ramanadham - Deputy Director, Office of Policy for Pharmaceutical Quality, OPQ, CDER, U.S. Food and Drug Administration will share insights on strengthening product lifecycle management from both technical and regulatory standpoints at IPA’s 9th Advanced GMP Workshop 2024.

Date: 22 – 23 October 2024
Time: 3:00 – 8:00 pm IST
Virtual

Register Now: https://bit.ly/4gHz9nS

19/10/2024

IPA’s 9th Advanced GMP Workshop 2024 is just 3 days away.
Join us to gain the latest insights from regulators, government officials, industry experts and consultants.

Date: 22 – 23 October 2024
Time: 3:00 – 8:00 pm IST
Virtual

Register Now: https://bit.ly/4gHz9nS

Lupin | U.S. Food and Drug Administration | Department of Pharmaceuticals | Dr. Reddy's Laboratories Ltd. | Sun Pharmaceutical Industries Limited | Cipla